Document Detail


Indomethacin for closure of patent ductus arteriosus in prematures.
MedLine Citation:
PMID:  7039927     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A controlled, double blind trial of indomethacin versus placebo was conducted in prematures of birth weight less than 1750 g, with a murmur of patent ductus arteriosus (PDA). The dose of indomethacin was 0.2 mg/kg for 2 doses, orally, 24 hours apart. Forty-seven patients entered the trial. Twenty-four received indomethacin and 12 of these met the criteria for response; 23 received the placebo and two met the criteria for response (p less than 0.01). Subsequent surgical ligation for symptomatic PDA was required in 13 of 23 in the placebo group and 4 of 24 in the indomethacin group (p less than 0.01). When administered early, indomethacin is moderately effective in closing PDA in premature infants.
Authors:
M D Mullett; T W Croghan; D Z Myerberg; J M Krall; W A Neal
Related Documents :
15358467 - Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet for...
3086937 - Prostacyclin and steroidogenesis in goat ovarian cell types in vitro.
12789117 - A comparative study of vaginal misoprostol and intravenous oxytocin for induction of la...
3413197 - Influence of exogenously administered oxytocin on the corticosterone and prolactin resp...
264797 - Repeated chlorpromazine administration increases a behavioural response of rats to 5-hy...
24620447 - Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide ...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Clinical pediatrics     Volume:  21     ISSN:  0009-9228     ISO Abbreviation:  Clin Pediatr (Phila)     Publication Date:  1982 Apr 
Date Detail:
Created Date:  1982-06-14     Completed Date:  1982-06-14     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372606     Medline TA:  Clin Pediatr (Phila)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  217-20     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Double-Blind Method
Ductus Arteriosus, Patent / drug therapy*
Enterocolitis, Pseudomembranous / chemically induced
Gastrointestinal Hemorrhage / chemically induced
Humans
Indomethacin / adverse effects,  therapeutic use*
Infant, Newborn
Infant, Premature, Diseases / drug therapy*
Chemical
Reg. No./Substance:
53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical pharmacokinetics of paracetamol.
Next Document:  A microtechnique for radioisotopic determination of glomerular filtration rate in infants and childr...